Role of Circulating Tumor DNA in Adapting Immunotherapy Approaches in Breast Cancer
Immunotherapy has a defined role in the treatment of both early- and late-stage triple-negative breast cancer (TNBC) and is under active exploration in human epidermal receptor 2-positive as well as high-risk hormone-receptor-positive subtypes. It is critical to balance the efficacy and toxicity of...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/32/7/373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!